New Opportunities For VC-Backed Life Sciences Cos.
June 5, 2013, 1:04 PM EDT
Law360, New York (June 5, 2013, 1:04 PM EDT) -- The insatiable funding requirements of early-stage life sciences companies demand an unending and time-consuming quest for capital. Inevitably, the path leads to the door of venture capital firms, which have been a traditional source of financing for drug discovery, drug development, diagnostics and other capital-intensive life sciences businesses. However, the bar to raising venture capital, as well as the cost of that capital, continues to rise.
As a result, companies are devoting ever-increasing efforts to secure alternative nondilutive sources of funding from governmental agencies, patient advocacy...